Literature DB >> 21132576

Natural killer cell neoplasm: biology and pathology.

Maria Francisca Ham1, Young-Hyeh Ko.   

Abstract

Natural killer (NK) cell neoplasm is a heterogeneous disease group. In the latest World Health Organization (WHO) classification of tumours of hematopoietic and lymphoid tissues (2008), disease entities considered as NK-cell derivation include NK-lymphoblastic leukemia/lymphoma, chronic lymphoproliferative disorders of NK cells, aggressive NK-cell leukemia, and extranodal NK-cell lymphoma, nasal-type. Despite recent advances in NK-cell research, which have expanded our understanding of the biology of NK-cell neoplasm, it cannot yet be sharply delineated from myeloid neoplasms and T-cell neoplasms even in some "well-known" entity, such as extranodal NK/T-cell lymphoma. This review describes current knowledge of the biology of NK cells and pathology of NK neoplasms as classified in the 2008 WHO classification of tumours of hematopoietic and lymphoid tissues.

Entities:  

Mesh：

Year:  2010        PMID： 21132576     DOI： 10.1007/s12185-010-0738-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  72 in total

1.  Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

Authors:  Lijun Shen; Anthony C T Liang; Liwei Lu; Wing Yan Au; Yok-Lam Kwong; Raymond H S Liang; Gopesh Srivastava
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.

Authors:  J Iqbal; D D Weisenburger; A Chowdhury; M Y Tsai; G Srivastava; T C Greiner; C Kucuk; K Deffenbacher; J Vose; L Smith; W Y Au; S Nakamura; M Seto; J Delabie; F Berger; F Loong; Y-H Ko; I Sng; X Liu; T P Loughran; J Armitage; W C Chan
Journal:  Leukemia       Date:  2010-11-05       Impact factor: 11.528

3.  Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.

Authors:  R Nash; P McSweeney; R Zambello; G Semenzato; T P Loughran
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

4.  Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology.

Authors:  P M Kluin; A Feller; P Gaulard; E S Jaffe; C J Meijer; H K Müller-Hermelink; S Pileri
Journal:  Histopathology       Date:  2001-03       Impact factor: 5.087

5.  Chemokine system and tissue infiltration in aggressive NK-cell leukemia.

Authors:  Hideki Makishima; Toshiro Ito; Kayoko Momose; Hideyuki Nakazawa; Shigetaka Shimodaira; Yuji Kamijo; Yozo Nakazawa; Naoaki Ichikawa; Mayumi Ueno; Hikaru Kobayashi; Kiyoshi Kitano; Hiroshi Saito; Kendo Kiyosawa; Fumihiro Ishida
Journal:  Leuk Res       Date:  2006-11-22       Impact factor: 3.156

6.  Nasal-type extranodal natural killer/T-cell lymphoma presenting with extensive leg ulcers.

Authors:  H Y Chia; H L Tey; K B Tan; W S Chong
Journal:  Clin Exp Dermatol       Date:  2009-07-03       Impact factor: 3.470

Review 7.  Progress in understanding and managing natural killer-cell malignancies.

Authors:  Kazuo Oshimi
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

8.  Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings.

Authors:  J H Kim; J H Lee; J Lee; S-O Oh; D K Chang; P-L Rhee; J J Kim; J C Rhee; J Lee; W S Kim; Y H Ko
Journal:  Endoscopy       Date:  2007-02       Impact factor: 10.093

Review 9.  Granzymes in cancer and immunity.

Authors:  S P Cullen; M Brunet; S J Martin
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

10.  Precursor natural killer cell leukemia.

Authors:  Xiayuan Liang; Brian Greffe; Timothy Garrington; Douglas K Graham
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167
View more
  8 in total

1.  Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.

Authors:  Fumihiro Ishida; Young Hyeh Ko; Won Seog Kim; Junji Suzumiya; Yasushi Isobe; Kazuo Oshimi; Shigeo Nakamura; Ritsuro Suzuki
Journal:  Cancer Sci       Date:  2012-03-23       Impact factor: 6.716

2.  Blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.

Authors:  Yi-Wei Zhang; Ji-Hua Zhong; Xiao-Long Chen; Fei Xiao; Fang-Yuan Chen
Journal:  Exp Ther Med       Date:  2016-04-15       Impact factor: 2.447

3.  A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient.

Authors:  Umberto M Donato; Celeste Shoeleh; Andrew Galligan
Journal:  Cureus       Date:  2022-06-03

4.  Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.

Authors:  Junshik Hong; Sanghui Park; Hae Lim Baek; Joo Hyun Jung; Il Gyu Kang; Sun Jin Sym; Jinny Park; Jeong Yeal Ahn; Eun Kyung Cho; Seon Tae Kim; Dong Bok Shin; Jae Hoon Lee
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

5.  Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer/T-cell lymphoma in an 18-year-old girl: A case report.

Authors:  Yawei Xing; Junwen Yang; Guanghui Lian; Shuijiao Chen; Linlin Chen; Fujun Li
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  Comparison of Diagnostic Cytomorphology of Natural Killer/T-Cell Lymphoma (Nasal Type) in Conventional Smears, Liquid-Based Preparations, and Histopathology.

Authors:  Chih-Yi Liu; Hui-Chih Tsai
Journal:  Case Rep Pathol       Date:  2018-05-14

7.  Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.

Authors:  Jia-Jia Huang; Ya-Jun Li; Yi Xia; Yu Wang; Wen-Xiao Wei; Ying-Jie Zhu; Tong-Yu Lin; Hui-Qiang Huang; Wen-Qi Jiang; Zhi-Ming Li
Journal:  BMC Cancer       Date:  2013-05-03       Impact factor: 4.430

8.  Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Authors:  Ly Quoc Trung; J Luis Espinoza; Akiyoshi Takami; Shinji Nakao
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.